Feed LFCR
LF

Lifecore Biomedical, Inc.

LFCR · NASDAQ

$4.48 +1.93% (+$0.09)
1M -1.54%
Market Cap $167.3M
P/E Ratio -
Div. Yield -
ROE 376.95%
Piotroski F-Score Moderate
4/9
Valuation
95 /100
Cheap
P/S 1.36x
P/E N/A
EV/EBITDA N/A
Growth
35 /100
Stable
Rev. growth 5.02%
Book val. growth 75.22%
EPS growth N/A
Profitability
11 /100
Weak
Gross margin 29.68%
Net margin 30.40%
Op. margin 2.12%
Quality
7 /100
Poor
ROIC 1.26%
ROE 376.95%
ROA 16.25%
Debt
43 /100
Moderate
Current ratio 3.87x
Int. coverage -0.46x
Debt/Equity N/A
Stability
40 /100
Moderate
Beta 1.09x
Rev. volatility 16.37%
EPS volatility 319.83%

Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe

Întreabă StockBot despre LFCR
Online

Despre companie

Lifecore Biomedical, Inc. (LFCR) is an American biotechnology company specializing in the development and manufacturing of medical devices and biopharmaceutical products. The company is known for its expertise in hyaluronic acid and its medical applications, offering products for ophthalmic surgery, orthopedics, and aesthetic medicine. Lifecore Biomedical focuses on innovation and continuous improvement of its products to meet the highest standards of quality and efficiency. Lifecore Biomedical, Inc. (LFCR) shares could be suitable for investors looking for investments in the biotechnology and medical devices sector with an emphasis on innovative and specialized products.

Nu este încă disponibil în limba dumneavoastră, așa că textul este în engleză.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Paul Josephs

Employees

382

Headquarters

Chaska

Evenimente viitoare

03 NOV.

Earnings

Upcoming earnings report

42d

Folosim cookie-uri esențiale pentru funcționarea site-ului și cookie-uri analitice opționale pentru a măsura utilizarea. Consultați Politica de confidențialitate.